More and more people in the Asia-Pacific region are having heart issues. The market for invasive cardiology is growing very quickly because of this. Interventional cardiology is getting increasingly common as heart disease rates rise. Lack of exercise, bad diet, and aging are contributing to this surge in instances.
Interventional cardiac therapies now have more advanced instruments. Medicine is increasingly using bioresorbable, drug-eluting, and minimally invasive stents. Complex and less intrusive methods improve patient outcomes. It boosts the market.
Health care costs will rise with Asia-Pacific corporations. Heart centers and other healthcare facilities get a lot of governmental and private funding. There is more money going into the invasive heart business, which helps it grow.
The market is growing because more people know how important it is to have a healthy heart and because exercise programs work well. Interventional cardiology treatments are becoming more popular because governments, non-profits, and health care workers are running programs to teach people how to avoid heart problems and how important it is to move quickly.
Health care services are being tried to reach rural places in order to help the market grow. At the same time that work is being done to make invasive heart treatments available in farther away places, differences in the availability of health care are being narrowed. More people are likely to want invasive heart tools and treatments because of this growth and spread into rural places.
As study centers, healthcare workers, and companies that make medical devices work together more, the market for these devices grows and new ideas are born. Asia-Pacific healthcare needs cutting-edge technology and savvy connections to tackle its difficulties.
Asia-Pacific nations are implementing several non-communicable disease policies and initiatives, focusing on heart health. By screening, raising awareness, and financing health care, the invasive cardiology industry has grown well.
More consumers seek affordable, high-quality medical care. Healthcare seekers are increasingly choosing Asia-Pacific. The market is growing even faster because invasive heart projects are being done on people from other countries in places like India, Singapore, and Thailand.
Even though the rules for compensation have been made better, some people still have to pay more for therapeutic heart treatments because of problems with the rules. To keep the market growing and make sure that everyone has the same chance to get improved heart care, it is very important to fix these problems with pay.
The work that is being done now will shape the future of invasive cardiology in the Asia-Pacific area. The market is getting ready for more changes as people look for new tools, better ways to do things, and more personalized ways to help patients. This makes me think of new ideas.
Asia Pacific Interventional Cardiology Market Size was valued at USD 1.51 Billion in 2023. The Global Asia Pacific Interventional Cardiology industry is projected to grow from USD 1.59 Billion in 2024 to USD 2.82 Billion by 2032, exhibiting a compound annual growth rate (CAGR) of 8.21% during the forecast period (2024 - 2032).
Interventional cardiology is a branch of cardiology that deals with catheter based treatment for heart diseases. By catheterization, number of procedures can be performed on the heart. According to International Diabetes Federation, 60% of world’s total diabetic population lives in Asia. Diabetic is one of the major factors which lead to cardiovascular diseases. Increasing prevalence of cardiovascular diseases is the major factor for the growth of the market in Asia Pacific. Beside this increasing incidences of diabetes and obesity, change in lifestyle, increasing awareness among the people and rapid development in technology also contributed to the growth of the market. On other hand, high cost for manufacturing the devices and lot of barriers for the development of the new device are the major restraints hampering the market growth.
Segmentation
Asia Pacific interventional cardiology market is segmented on the basis of type, into catheters, stents, balloons, vascular closure devices, laser procedures, atherectomy and other. Stents are sub segmented into metal stents, drug eluting stents and bioresorbable stents. Balloons are further segmented into cutting balloons, drug eluting balloons and other. On the basis of end users the Asia Pacific interventional cardiology market is segmented into catheterization laboratories, hospitals and clinics and others
Regional Analysis:
On the basis of region, Asia Pacific interventional cardiology market is segmented into countries namely Japan, India, China, Australia, Republic of Korea and Rest of Asia Pacific. China accounts for the largest market share which is attributed to an increase in incidence of chronic heart diseases, increasing geriatric population, and demand for early diagnosis of cardiac disease. India holds the second largest market whereas Japan shows steady growth in this market.
Key Players for Asia Pacific interventional cardiology market
Abbott Laboratories Inc. (U.S.), B. Braun Melsungen AG (Germany), C.R. Bard, Inc. (U.S.), Abiomed Inc. (U.S), Edwards Lifesciences (U.S.), Biosensors International Group, Ltd. ( Singapore), Boston Scientific Corporation (U.S.), Medtronic PLC (Ireland), Angiodynamics, Inc. ( U.S), Terumo Medical Corporation (Japan), Johnson & Johnson Services, Inc. (U.S.)., Lombard Medical Technologies, Plc. (U.K), Clearstream Technologies Group Plc. (Ireland).
Study objectives Asia Pacific interventional cardiology market
Intended Audience
The report for Asia Pacific interventional cardiology market of Market Research Future comprises of extensive primary research along with the detailed analysis of qualitative as well as quantitative aspects by various industry experts, key opinion leaders to gain the deeper insight of the market and industry performance. The report gives a clear picture of the current market scenario which includes historical and projected market size in terms of value and volume, technological advancement, macro economical and governing factors in the market. The report provides details information and strategies of the top key players in the industry. The report also gives a broad study of the different markets segments and regions.
© 2024 Market Research Future ® (Part of WantStats Reasearch And Media Pvt. Ltd.)